- Home
- PMF vs TCMD Comparison
PMF vs TCMD Comparison
Compare PMF & TCMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PMF
- TCMD
- Stock Information
- Founded
- PMF 2001
- TCMD 1995
- Country
- PMF United States
- TCMD United States
- Employees
- PMF N/A
- TCMD N/A
- Industry
- PMF Finance/Investors Services
- TCMD Medical/Dental Instruments
- Sector
- PMF Finance
- TCMD Health Care
- Exchange
- PMF Nasdaq
- TCMD Nasdaq
- Market Cap
- PMF 209.2M
- TCMD 235.5M
- IPO Year
- PMF N/A
- TCMD 2016
- Fundamental
- Price
- PMF $7.72
- TCMD $10.31
- Analyst Decision
- PMF
- TCMD Hold
- Analyst Count
- PMF 0
- TCMD 3
- Target Price
- PMF N/A
- TCMD $16.00
- AVG Volume (30 Days)
- PMF 61.3K
- TCMD 176.4K
- Earning Date
- PMF 01-01-0001
- TCMD 08-04-2025
- Dividend Yield
- PMF 5.36%
- TCMD N/A
- EPS Growth
- PMF N/A
- TCMD N/A
- EPS
- PMF N/A
- TCMD 0.66
- Revenue
- PMF N/A
- TCMD $293,164,000.00
- Revenue This Year
- PMF N/A
- TCMD $7.96
- Revenue Next Year
- PMF N/A
- TCMD $8.53
- P/E Ratio
- PMF N/A
- TCMD $15.57
- Revenue Growth
- PMF N/A
- TCMD 5.96
- 52 Week Low
- PMF $7.69
- TCMD $8.61
- 52 Week High
- PMF $10.56
- TCMD $21.10
- Technical
- Relative Strength Index (RSI)
- PMF 39.18
- TCMD 52.71
- Support Level
- PMF $7.68
- TCMD $10.09
- Resistance Level
- PMF $7.82
- TCMD $10.76
- Average True Range (ATR)
- PMF 0.07
- TCMD 0.38
- MACD
- PMF -0.00
- TCMD 0.08
- Stochastic Oscillator
- PMF 19.35
- TCMD 66.79
About PMF PIMCO Municipal Income Fund
PIMCO Municipal Income Fund is a closed-end management investment company. Its primary investment objective is to seek to provide current income exempt from federal income tax. The fund invests a majority of its net assets in municipal bonds that pay interest that is exempt from federal income tax.
About TCMD Tactile Systems Technology Inc.
Tactile Systems Technology Inc is a medical technology company. The company is engaged in developing and providing medical devices for the treatment of chronic diseases. The firm's proprietary platform flexitouch system provides a home-based solution for lymphedema patients. The entire system is another home solution for patients with chronic swelling and actitouch system for chronic venous insufficiency patients that may be worn throughout the day.